Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities (Tables)

v3.24.2
Accrued Expenses and Other Current Liabilities (Tables)
 3 Months Ended
Mar. 31, 2024
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities as of March 31, 2024 and December 31, 2023 consisted of the following (in thousands): 
  As of
  March 31, 2024 December 31, 2023
Research and development $ 329  $ 352 
Compensation and benefits 752  580 
General and administrative (including asset acquisition related transaction costs) 1,934  830 
Private placement investment transaction costs 2,034  — 
Commercial operations 1,789  1,873 
Lease liability, current 545  537 
Total accrued expenses and other current liabilities $ 7,383  $ 4,172